Back to the future: Oral small molecule kinases: Small molecule kinase inhibitors, what are they and how are they effective?

Rheumatology (United Kingdom)

Volumn 52, Issue 7, 2013, Pages 1153-1154

  Fleischmann, Roy ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b METROPLEX CLINICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; JANUS KINASE; METHOTREXATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE IV; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE; PROTEIN KINASE SYK; STAT PROTEIN; TOFACITINIB; TUMOR NECROSIS FACTOR INHIBITOR;

CELL GROWTH; CELL INTERACTION; HUMAN; MONOTHERAPY; MUTAGENESIS; NOTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK FACTOR; SIGNAL TRANSDUCTION;

ARTHRITIS, RHEUMATOID; DRUG DISCOVERY; HUMANS; PROTEIN KINASE INHIBITORS;

EID: 84879826324     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket155     Document Type: Note

References (10)

1. Forestier J. Rheumatoid arthritis and its treatment with gold salts-results of six years experience. J Lab Clin Med 1935;20:827-840.
2. Hench PS, Kendall EC. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 1949;24:181-97.
3. Hench PS, Kendall EC, Slocumb CH et al. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Intern Med 1950;85:545-666.
4. Strand V, Cohen S, Schiff M et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med 1999;159: 2542-50.
5. O'Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012;36:542-50.
6. O'Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 2013;368:161-70.
7. Vaddi K, Luchi M. JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy. Expert Opin Investig Drugs 2012;21: 961-73.
8. Kelly V, Genovese M. Novel small molecule therapeutics in rheumatoid arthritis. Rheumatology 2013; 52:1155-62.
9. Feist E, Burmester GR. Small molecules targeting JAKs-a new approach in the treatment of rheumatoid arthritis. Rheumatology 2013;52:doi:10.1093/rheumatology/ kes417.
10. Nijjar JS, Tindell A, McInnes IB et al. Inhibition of spleen tyrosine kinase in the treatment of rheumatoid arthritis. Rheumatology 2013;52:doi:10.1093/rheumatology/ ket225.